Northern Trust Corp Meridian Bioscience Inc Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $380,310 - $407,658	12,209 Added 2.26%	551,260 $18.3 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $9,826 - $10,668	-318 Reduced 0.06%	539,051 $17 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $24,652 - $32,894	1,038 Added 0.19%	539,369 $16.4 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $240,279 - $324,142	-12,032 Reduced 2.19%	538,331 $14 Million
Q4 2021 Feb 08, 2022	SELL	$17.46 - $21.61 $240,459 - $297,612	-13,772 Reduced 2.44%	550,363 $11.2 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $311,259 - $403,650	-17,940 Reduced 3.08%	564,135 $10.9 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $857,618 - $1.35 Million	47,619 Added 8.91%	582,075 $12.9 Million
Q1 2021 May 12, 2021	SELL	$19.76 - $29.89 $680,376 - $1.03 Million	-34,432 Reduced 6.05%	534,456 $14 Million
Q4 2020 Feb 11, 2021	SELL	$15.73 - $21.66 $389,191 - $535,911	-24,742 Reduced 4.17%	568,888 $10.6 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $337,795 - $658,876	-24,948 Reduced 4.03%	593,630 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $530,642 - $1.58 Million	67,684 Added 12.29%	618,578 $14.4 Million
Q1 2020 May 14, 2020	SELL	$5.57 - $11.5 $41,641 - $85,974	-7,476 Reduced 1.34%	550,894 $4.63 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $4,566 - $5,860	578 Added 0.1%	558,370 $5.46 Million
Q3 2019 Nov 13, 2019	SELL	$9.17 - $12.01 $112,433 - $147,254	-12,261 Reduced 2.15%	557,792 $5.3 Million
Q2 2019 Aug 13, 2019	SELL	$10.88 - $17.6 $301,735 - $488,100	-27,733 Reduced 4.64%	570,053 $6.77 Million
Q1 2019 May 13, 2019	BUY	$15.51 - $17.61 $568,332 - $645,283	36,643 Added 6.53%	597,786 $10.5 Million
Q4 2018 Feb 12, 2019	SELL	$14.52 - $19.72 $246,999 - $335,456	-17,011 Reduced 2.94%	561,143 $9.74 Million
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $269,750 - $296,997	18,165 Added 3.24%	578,154 $8.62 Million
Q2 2018 Sep 18, 2018	SELL	$13.8 - $16.8 $38,005 - $46,267	-2,754 Reduced 0.49%	559,989 $8.9 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $177,647 - $216,266	12,873 Added 2.34%	562,743 $8.95 Million
Q1 2018 May 09, 2018	BUY	$13.8 - $16.2 $54,013 - $63,406	3,914 Added 0.72%	549,870 $7.81 Million
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $94,280 - $109,936	-6,958 Reduced 1.26%	545,956 $7.64 Million
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $7.44 Million - $7.93 Million	552,914	552,914 $7.91 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account